FIT Biotech Oy, Tartu, Estonia.
Vaccine. 2009 Dec 11;28(2):293-8. doi: 10.1016/j.vaccine.2009.10.054. Epub 2009 Oct 29.
Broad CTL response against HIV-1 is one factor that helps to control the viral replication. We have constructed a DNA vaccine that encodes a large artificial fusion protein (MultiHIV) and shown it to be immunogenic in mice, swine and macaques. Inbred mice revealed CTL response only against two epitopes due to limited MHC class I variability. To assess the quality of the CTL response we addressed this question in domestic swine. Number of presented epitopes varied between 7 and 14 among the five selected animals. Epitopes detected in swine are localised in the same antigenic regions recognised in humans. This can be explained by the fact that swine MHC-I (SLA-I) complex is remarkably similar to human HLA-I. These results also indicate that immunogenicity profile of vaccines in domestic swine may predict the outcome of human immunisation.
广谱 CTL 反应是有助于控制病毒复制的因素之一。我们构建了一种 DNA 疫苗,该疫苗编码一种大型人工融合蛋白(MultiHIV),并已证明其在小鼠、猪和猕猴中具有免疫原性。由于 MHC Ⅰ类变异性有限,近交系小鼠仅对两个表位产生 CTL 反应。为了评估 CTL 反应的质量,我们在国内猪中研究了这个问题。在 5 只选定的动物中,呈递的表位数量在 7 到 14 之间变化。在猪中检测到的表位定位于人类识别的相同抗原区域。这可以用这样一个事实来解释:猪 MHC-I(SLA-I)复合物与人类 HLA-I 非常相似。这些结果还表明,国内猪的疫苗免疫原性谱可能预测人类免疫的结果。